サイヤジェン Company Profile

Founded as a contract research organization for pharmaceutical development and a manufacturer of cell-related products, a leading company in the creation of genetically modified animal models.

In 2005, we were established as a contract research organization for pharmaceutical development and a manufacturer of cell-related products. Currently, we have 400 employees worldwide. Our headquarters is located in Silicon Valley, California, USA, with manufacturing bases in Suzhou and Guangzhou, China. In 2016, we opened a branch in Tokyo, Japan. As a leading company in the production of genetically modified animal models, we provide high-quality reagents and tools at reasonable prices. 1. Production of genetically modified animal models: As a leading company in the contract production of rodent animal models, we offer a one-stop service that is optimal for research. Our services range from vector construction and ES cell manipulation to microinjection production, allowing us to accept contracts for animal model production at any stage of the process. We are also engaged in contract services for animal models using the CRISPR-Cas9 system and artificial nuclease technology. Compared to gene targeting technology, artificial nuclease technology can save time and costs in production.